Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
News provided by FuturHealth Jul 30, 2025, 15:57 ET As restrictions tighten on compounded semaglutide, FuturHealth now offers name-brand GLP-1slike Wegovy through Novo's cash-pay program SAN DIEGO, July 30, 2025 /PRNewswire/ -- FuturHealth , a leading provider of personalized weight-loss solutions, today announced it is giving its members seamless access to FDA-approved GLP-1 medications - including Wegovy - at highly affordable, cash-pay prices, delivered directly to their doors
Virtual dietitian networks make it easier to serve members across large and dispersed workforces
The GH/IGF-1 axis drives several metabolic effects, with the most notable being enhanced lipolysis in visceral adipose tissue
If you are using a vial and syringe for reconstituted semaglutide or reconstituted tirzepatide , select a 31-gauge insulin syringe
US$ 23.32
US$ 20.87
US$ 25.39
US$ 25.98
US$ 20.54
